Total Funding
33
41
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119390
Atriomx develops a solution that delivers deep electrophysiology insights via non-invasive clinical hardware.
- Duke Rohlen: CEO & ChairmanPast Role: EPIX Therapeutics, Co-founder, CEO and Chairman
- Mike Carter: Chief Operating Officer
About the Company
Atriomx develops a solution that delivers deep electrophysiology insights via non-invasive clinical hardware. Atriomx is leveraging advanced data science to transform the way cardiac arrhythmias are understood and improve the way patients are treated - before they undergo costly and invasive treatments. Atriomx’s proprietary algorithms provide
unparalleled insight into a patient’s disease state, giving doctors and patients the information they need in order to decide with confidence which treatment is right for each individual patient.
